TAMPA, Fla. - TelAve -- Claimalytics, LLC today announced the launch of atlas-ai, a first-of-its-kind agentic AI platform designed specifically for the healthcare industry. atlas-ai launches with 12 purpose-built AI agents organized across three operational tiers, with additional agents in continuous development, to transform how health plans, pharmacy benefit managers (PBMs), and provider organizations handle the most complex, time-intensive workflows in pharmacy benefit management.

atlas-ai Platform Overview
atlas-ai is architected around a three-tier agent framework that mirrors the operational structure of pharmacy benefit management.

Built on Public Drug Data Infrastructure
atlas-ai leverages a proprietary drug data resolution pipeline built on RxNorm, the National Library of Medicine's drug normalization standard. By resolving drug identifiers at the Semantic Clinical Drug (SCD) level using RxCUI, atlas-ai can reliably match free-text drug names, NDC codes, and formulary entries across manufacturer and labeling variations. The platform also integrates data from CMS (NADAC, Medicare Part D, ASP), the FDA NDC Directory, DailyMed labeling, and state Medicaid Preferred Drug Lists to deliver real-time formulary intelligence and drug pricing context.

More on TelAve News

• Clash of Prompts: The World's First AI Prompt Battle Royale
• $7.6 Billion US Crypto ATM Market by 2034; California and Texas Crypto ATM Deployments for Bitcoin Bancorp (Stock Symbol: BCBC); 1000 Kiosk Inventory
• MainConcept Announces Multiview Encoding for Apple Immersive Video
• CCHR Rejects Global Psychiatric Push to Electroshock Children
• iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity

Private AI Models with Verified, Controlled Sources
All Claimalytics products and agents are powered by private AI models that operate within a controlled data environment. Unlike general-purpose AI systems that draw from the open internet, atlas-ai and its agents do not have unrestricted access to external web content. Every source referenced, cited, or used by the AI models has been vetted, verified, and approved by Claimalytics before it enters the platform's knowledge base.

This controlled-source architecture is a deliberate design decision for the healthcare industry, where accuracy and traceability are not optional. By restricting the AI models to approved data sources such as CMS publications, FDA databases, DailyMed labeling, RxNorm, state Medicaid formularies, and other verified clinical and regulatory references, Claimalytics ensures that every response, recommendation, and output generated by the platform is grounded in material that meets the company's standards for reliability and clinical validity. No unverified, uncontrolled, or unapproved internet content is used by any Claimalytics agent or product.

More on TelAve News

• Americans Leave Behind or Discard 42% of Their Belongings When Moving Out for the First Time, Talker Research Finds
• Central Florida Luxury Real Estate Firm DANHOLM COLLECTION Partners with Luxury Presence to Expand Global Buyer Reach
• Advantage Marketing Launches 3-Minute Assessment to Help SMBs Diagnose and Fix Marketing Gaps
• InterMountain Management Announces the Re-opening of Holiday Inn Express & Suites Alexandria
• CB Stuffer Expands New England Footprint with Launch at Common Man Roadside in Hooksett, NH

View Full Press Release: https://www.claimalytics.com/newsroom/atlas-ai-launch

About Claimalytics
Claimalytics, LLC is a Tampa-based healthcare technology company building AI-powered analytics and automation products for the pharmacy benefit management industry. The company's product suite, including atlas-ai, cortex-ai, and claim analyzer, is designed to bring intelligence, transparency, and efficiency to the most complex workflows in healthcare. For more information, visit claimalytics.com.